Clinical trial design involves structuring studies to evaluate the safety and efficacy of medical interventions. Key phases include Phase I, focusing on safety and dosage with 20-100 participants, Phase II assessing efficacy with 100-300 patients, Phase III confirming effectiveness in 300-3,000 participants, and Phase IV for post-market studies